Cargando…
Hepatitis C Virus NS3/4A Protease Inhibitors: A Light at the End of the Tunnel
Hepatitis C virus (HCV) infection is a serious and growing threat to human health. The current treatment provides limited efficacy and is poorly tolerated, highlighting the urgent medical need for novel therapeutics. The membrane-targeted NS3 protein in complex with the NS4A comprises a serine prote...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Molecular Diversity Preservation International (MDPI)
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3185733/ https://www.ncbi.nlm.nih.gov/pubmed/21994705 http://dx.doi.org/10.3390/v2081752 |